Clinical Laboratory Tests Market Report 2026

The clinical laboratory tests market size has grown rapidly in recent years. It will grow from $150.29 billion in 2025 to $167.55 billion in 2026 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to increasing prevalence of chronic and infectious diseases, expansion of routine health screening programs, growth of centralized laboratory testing facilities, rising physician reliance on lab diagnostics, improved access to diagnostic services.

The clinical laboratory tests market size is expected to see rapid growth in the next few years. It will grow to $256.15 billion in 2030 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to increasing demand for personalized diagnostics, expansion of decentralized and point-of-care testing, growing integration of digital pathology, rising investments in laboratory automation, increasing adoption of predictive diagnostics. Major trends in the forecast period include increasing adoption of automated diagnostic testing platforms, rising demand for high-throughput laboratory testing, growing use of AI-assisted test interpretation, expansion of preventive and screening test programs, enhanced focus on test accuracy and standardization.

The rising obesity levels are expected to drive the growth of the clinical laboratory tests market going forward. Obesity levels indicate the prevalence of obesity within a population, typically assessed using body mass index (BMI) criteria. The increase in obesity levels is largely attributed to sedentary lifestyles, where reduced physical activity creates an imbalance between calorie intake and expenditure, leading to excess fat accumulation. Clinical laboratory tests aid in monitoring and managing obesity by detecting underlying health issues, such as hormonal imbalances, metabolic disorders, or nutrient deficiencies, and by tracking obesity-related risk factors like blood glucose, cholesterol, and liver function, thereby supporting personalized treatment plans. For instance, in May 2024, the Office for Health Improvement & Disparities, a UK-based government agency, reported that in England, 64% of adults aged 18 and over were estimated to be overweight or living with obesity in 2022-2023. Therefore, the rising obesity levels are propelling the growth of the clinical laboratory tests market.

Major companies operating in the clinical laboratory tests market are focusing on developing advanced solutions, such as consumer-initiated genetic tests, to enhance personalized healthcare, increase patient engagement, and expand access to diagnostic services. Consumer-initiated genetic testing allows individuals to request genetic tests directly without a physician’s referral, providing insights into their health risks, ancestry, or genetic traits through DNA analysis. For instance, in July 2023, Quest Diagnostics Inc., a US-based medical laboratory company, introduced genetic insights to deliver personalized health risk information based on an individual’s genetic profile. The test analyzes 36 genes using advanced next-generation sequencing to assess risks for nearly two dozen inheritable conditions, providing tailored, actionable health reports that include physician oversight and complimentary genetic counseling. This saliva-based test empowers individuals to proactively explore their genetic health risks.

In December 2024, Wildcat DX LLC, a US-based healthcare services company, acquired Navis Clinical Laboratories Inc. for an undisclosed amount. Through this acquisition, Wildcat DX aims to leverage its business network to enhance Navis’s reputation, expand its capabilities, and strengthen growth, supporting projected synergies and combined annual revenues of approximately $200 million. Navis Clinical Laboratories Inc. is a US-based clinical laboratory company that provides a range of clinical laboratory tests.

Major companies operating in the clinical laboratory tests market are Roche Diagnostics, Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Labcorp, Mayo Clinic Laboratories, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, bioMérieux SA, Bio-Rad Laboratories Inc., QIAGEN NV, Cepheid Inc., OPKO Health Inc., ARUP Laboratories, Thyrocare Technologies Limited, Unilabs Diagnostics AB, Ortho Clinical Diagnostics, Randox Laboratories Ltd, Sysmex Corporation.

North America was the largest region in the clinical laboratory tests market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical laboratory tests market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clinical laboratory tests market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the clinical laboratory tests market by increasing costs of imported diagnostic instruments, reagents, consumables, and laboratory automation systems. Hospitals and diagnostic laboratories in North America and Europe are most affected due to dependence on imported testing equipment, while Asia-Pacific faces cost pressures on reagent supply chains. These tariffs are raising testing costs and affecting laboratory margins. At the same time, they are encouraging domestic reagent manufacturing, localized equipment assembly, and investment in regional diagnostic production capabilities.

The clinical laboratory tests market research report is one of a series of new reports that provides clinical laboratory tests market statistics, including clinical laboratory tests industry global market size, regional shares, competitors with a clinical laboratory tests market share, detailed clinical laboratory tests market segments, market trends and opportunities, and any further data you may need to thrive in the clinical laboratory tests industry. This clinical laboratory tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Clinical laboratory tests refer to medical diagnostic analyses performed on samples such as blood, urine, tissue, or other bodily fluids to detect, diagnose, monitor, or prevent disease. These tests provide critical data to aid physicians in making informed clinical decisions and are commonly used in routine health checkups, disease screening, and treatment monitoring.

The main types of clinical laboratory tests are complete blood count, hemoglobin or hematocrit testing, basic metabolic panel testing, blood urea nitrogen creatinine testing, electrolyte testing, HbA1c testing, comprehensive metabolic panel testing, liver panel testing, renal panel testing, and others. A complete blood count (CBC) is a diagnostic test that evaluates the levels of different blood cells to help detect infections, anemia, and other hematological conditions. These services are delivered by hospital-based laboratories, stand-alone laboratories, and clinic-based laboratories. These are commonly applied in areas such as parasitology, virology, hematology, toxicology, immunology or serology, histopathology, and urinalysis and are widely used by central laboratories, hospitals, primary clinics, and others.

The clinical laboratory tests market includes revenues earned by entities by providing services such as routine and specialized lab testing services, and analytical support for disease detection and treatment planning. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.